Clinical Trial Update: Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin [Phase 4]

View source ↗

Summary

This Phase 4 trial assessed intensification with biphasic insulin aspart 30 in people with Type 2 diabetes inadequately controlled on sitagliptin and metformin.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2014-11-10